In the CHD group, being older (1.081, 95% CI [1.019, 1.417], p = 0.010) and lower albumin levels (0.544, 95% CI [0.323, 0.917], p = 0.022) were associated with a higher probability to develop HCC during the follow-up. The gene discussed is ALB; the disease is hepatocellular carcinoma.